Based on Safety Data Review, DMC Recommends Continuing Trial
September 26, 2019
Julie is an industry veteran with experience spanning management consulting, investment banking and business development
September 02, 2019
SHENZHEN, CHINA and ROCKVILLE, MD, July 11, 2019 — HighTide Therapeutics Inc. (“HighTide”), a clinical-stage biopharmaceutical company, today announced that it has become a resident company at JLABS @ Shanghai.
July 10, 2019